New Jersey Health Foundation (NJHF) has awarded 30 grants totaling more than $1 million for researchers in New Jersey who are working on health-related research that demonstrates exciting potential.
According to NJHF President James M. Golubieski, this round of funding for the New Jersey Health Foundation Research Grant Program was available for faculty members at these educational institutions— Princeton University, Rutgers University, Rowan University and Stevens Institute of Technology. New Jersey Health Foundation has historically funded more than $55 million in research grants to promote inventive science within the state.
Grants of up to $35,000 each will provide funding for researchers who are exploring a variety of areas including advancing a better understanding and treatments for those suffering from spinal cord injuries; Alzheimer's disease; sepsis; colon/rectal cancer; melanoma; periodontal disease; schizophrenia; breast cancer; tuberculosis; heart failure; pancreatic cancer; Lyme disease, infections and prostate cancer. Other research will advance the development of medical devices such as scaffolds, motion energy detectors and bionic organs.
Grants were awarded to recipients from these organizations:
North Jersey: Rutgers New Jersey Medical School; Rutgers School of Dental Medicine; Rutgers School of Health Related Professions; The Public Health Research Institute at Rutgers New Jersey Medical School; Stevens Institute of Technology
Central Jersey: Rutgers University; Rutgers Robert Wood Johnson Medical School; Rutgers Cancer Institute of New Jersey; Rutgers Ernest Mario School of Pharmacy; Rutgers School of Arts and Sciences; Rutgers New Jersey Center for Biomaterials
South Jersey: Cooper Medical School at Rowan University; Rowan College of Engineering; Rowan School of Osteopathic Medicine; Rowan College of Science and Mathematics
"Many of our past grant recipients have gone on to secure additional external funding from state and federal organizations including the National Institutes of Health to advance their projects," explained George F. Heinrich, M.D., vice chair and CEO. "New Jersey Health Foundation is proud to support these outstanding early stage research projects that may someday lead to innovative medical breakthroughs."
BMI's influence on disease pathogenesis uncovered in new research